[Federal Register Volume 62, Number 166 (Wednesday, August 27, 1997)]
[Notices]
[Page 45424]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22705]



[[Page 45424]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Biological Response Modifiers Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on September 17, 1997, 5 
p.m. to 7 p.m. by teleconference.
    Location: Food and Drug Administration, Bldg. 29, conference room 
121, 8800 Rockville Pike, Rockville, MD. This meeting will be held by a 
telephone conference call. A speaker telephone will be provided in the 
conference room to allow public participation in the meeting.
    Contact Person: Gail M. Dapolito or Rosanna L. Harvey, Center for 
Biologics Evaluation and Research (HFM-21), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12388. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The committee will discuss the intramural scientific 
programs of the Laboratory of Molecular and Developmental Immunology 
and an individual in the Molecular Immunology Laboratory.
    Procedure: On September 17, 1997, from 5 p.m. to 6 p.m., the 
meeting is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
September 10, 1997. Oral presentations from the public will be 
scheduled between approximately 5 p.m. and 6 p.m. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before September 10, 
1997, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Closed committee deliberations: On September 17, 1997, from 6 p.m. 
to 7 p.m., the meeting will be closed to permit discussion where 
disclosure would constitute a clearly unwarranted invasion of personal 
privacy (5 U.S.C. 552b(c)(6)). The meeting will be closed to discuss 
personal information concerning individuals associated with the 
research programs.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: August 19, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-22705 Filed 8-26-97; 8:45 am]
BILLING CODE 4160-01-F